News
Investigators studied the prevalence and outcomes of venous thromboembolic events (VTEs) among hospitalized patients with and without CKD.
SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System, a safer and more effective treatment of venous thromboembolism (VTE), was ...
Purpose Published evidence on the incidence and predictors of venous thromboembolism (VTE) in patients with cirrhosis of the liver is reviewed. Summary The frequently observed phenomenon of ...
A scientific statement regarding disparities in current pulmonary embolism management and outcomes has been published by the AHA.
Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.
Biosidus, an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has announced encouraging interim results from the Phase III SMILE1 ...
Background Diagnosis of venous thromboembolism (VTE) requires chest CT angiography for pulmonary embolism and venous ultrasound for deep vein thrombosis. To reduce imaging, guidelines recommend ...
Much of the research in optimizing anticoagulant therapy for acute VTE has been carried out in patients without malignancies. Given the aggressive natural history of VTE in cancer patients ...
6don MSN
“I’m neither late nor early.” Victor Wembanyama speaking publicly on his recovery after being diagnosed with deep vein ...
Phlebitis: A swelling of veins, phlebitis can cause pain, tenderness, or swelling in the affected area as well as warmth and ...
The Milwaukee Bucks announced in late March that star guard Damian Lillard has deep vein thrombosis in his right calf — a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results